819 articles
Liz Homans, CEO of Lyell Immunopharma, discusses how the company is tackling one of the hottest topics in cancer treatment: how to deploy cell therapy t...
Sue Washer, President and CEO of AGTC, a clinical-stage biotechnology company developing genetic therapies for people with rare and debilitating ophthal...
Norman Lepor, cardiologist and a clinical investigator in the Phase III clinical program for Leqvio ® (inclisiran), discusses the recent FDA approval...
Grant Simic, Executive Population Health Partner for U.S. Learn more on Health Professional Radio.
Colin Lake, Vice President of Digital Business Transformation for Neurology at UCB, discusses the company’s approach to digital solutions and how they...
David Henley, MD, Executive Medical Director, Alzheimer’s Disease Global Medical Affairs, Neurology Business Group at Eisai Inc.
Jean Ford a 78-year-old diabetic and cancer survivor discusses the challenges she faced from her type-II diabetes as well as the treatment plan and educ...
Michael Aragon, Chief Medical Officer of Outset Medical based in San Jose, California, discusses how the company is reducing the cost and complexity o...
Jean-Francois Boileau, MD, MSc, FRCSC, surgical oncologist at Jewish General Hospital Segal Cancer Centre; associate professor of surgery and oncology...
Maria Maccecchini, PhD, CEO of Annovis Bio discusses the company's lead program ANVS401 that has shown that it lowers levels of neurotoxic proteins f...